Tag Archive
Aesthetic Dentistry
Amenorrhea
Appendectomy
Arthritis
Brain Infections
Brain Surgery
Brain Tumors
Cancer
Cerebral Palsy
Cervical Excision Procedures
Cosmetic Dentistry
Curettage
Cystoscopy
Dental Implants
Dental Surgery
Dentistry
Diagnostic Laparoscopy
Dysmenorrhoea
Endodontics
Epilepsy
Exploratory Laparotomy
Fracture
Hysterectomy
Hysteroscopy
Infertility
Ligament Tear
Menorrhagia
Muscle Injury
Neurosurgery
Oophorectomy
Oral Health
Oral Health Problems
Pediatric Dentistry
Prosthodontics
Root Canal
Spinal Cord Tumors
Sports Injuries
Stroke
Stroke Rehabilitation
Stupor
Teeth Loss
Teeth Whitening
Tooth Decay
Tubal Ligation
Urinary Infections
Psychiatrists in Delhi
Psychiatrists in Delhi specialize in psychiatry and treat patients with mental & emotional disorders: Anxiety, Depression, Psychosis, Substance Abuse, Sexual Dysfunction etc. Most of the Delhi Psychiatrists specialize in the prevention, diagnosis, and treatment of mental, addictive, and emotional disorders and are trained in diagnostic evaluation and in psychotherapy. The practice of Psychiatry involves the... »
Latest news on Clinical Depression from Yahoo! News
- Clinical Trials Update: March 10, 2010 (HealthDay via Yahoo! News)
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com: - Evotec completes first-in-human Phase I study of EVT 103 for treatment-resistant depression (News-Medical-Net)
Evotec AG today announced two positive aspects that strengthen its integrated product development in treatment-resistant depression in its strategic alliance with Roche. - Research and Markets: Target Product Profiles 2009: Physician Insights on Key Attributes: Bipolar Depression (Business Wire via Yahoo! Finance)
DUBLIN----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Target Product Profiles 2009: Physician Insights on Key Attributes: Bipolar Depression" to their offering. - Clinical trial shows eprotirome drug reduces blood cholesterol (News-Medical-Net)
A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published today in the top-ranking scientific periodical The New England Journal of Medicine. - When Personality Makes Drugs Ineffective In Depression (Medical News Today)
A study published in the current issue of Psychotherapy and Psychosomatics addresses the role of personality factors in moderating treatment response in depression. The temperament harm avoidance (HA) has consistently demonstrated an association with major depressive disorder (MDD), serotonin functioning and reduction in depression symptoms in response to antidepressant medications targeting the ... - 10.03.2010 - PRESS RELEASE: Evotec Reports Good Progress in Product Development in Treatment-Resistant Depression in ... (4investors)
Evotec AG / Evotec Reports Good Progress in Product Development in Treatment-Resistant Depression in its Alliance with Roche processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. - Study on major depression published (The South End)
By: Aysha Jamali Professor assesses treatment across ethnic groups Fatigue, feelings of worthlessness, and recurring thoughts of death: these are some of the symptoms of major depression. It’s a disorder that affects approximately 14.8 million American adults in a given year, according to the National Institute of ... - Regina-produced documentary examines postpartum depression (Regina Leader-Post)
Elita Paterson knew something was wrong when she began experiencing heightened anxiety during her pregnancy. - Newly-Published Study Reinforces Role of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) as an Add-on Treatment that ... (redOrbit)
ATLANTA, March 11 /PRNewswire/ -- UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported the approval of Vimpat by the U.S. - HeartMath® LLC and Trajectory Health Collaborate to Measurably Reduce Stress and Improve Health in Corporate America (PRWeb via Yahoo! News)
HeartMath® LLC has announced a partnership with Dallas-based Trajectory Health LLC. The partnership will concentrate on measurably slowing the production of new disease before a catastrophic event occurs, working with companies to design, implement and evaluate clinical intervention programs with employees.
Clinical Depression Causes, Symptoms, Diagnosis, Treatment, and Prognosis